Abstract
Enzymes belonging to the PLA2 superfamily catalyze the hydrolysis of unsaturated fatty acids from the sn-2 position of glycerol moiety of neural membrane phospholipids. The PLA2 superfamily is classified into cytosolic PLA2 (cPLA2), calcium-independent PLA2 (iPLA2), plasmalogen-selective PLA2 (PlsEtn-PLA2) and secretory PLA2 (sPLA2). PLA2 paralogs/splice variants/isozymes are part of a complex signal transduction network that maintains cross-talk among excitatory amino acid and dopamine receptors through the generation of second messengers. Individual paralogs, splice variants and multiple forms of PLA2 may have unique enzymatic properties, tissue and subcellular localizations and roles in various physiological and pathological situations, hence tight regulation of all PLA2 isoforms is essential for normal brain function. Quantitative RT-PCR analyses show significantly higher expression of iPLA2 than cPLA2 in all regions of the rat brain. Upregulation of the cPLA2 family is involved in degradation of neural membrane phospholipids and generation of arachidonic acid-derived lipid metabolites that have been implicated in nociception, neuroinflammation, oxidative stress and neurodegeneration. In contrast, studies using a selective iPLA2 inhibitor, bromoenol lactone, or antisense oligonucleotide indicate that iPLA2 is an important “housekeeping” enzyme under normal conditions, whose activity is required for the prevention of vacuous chewing movements, and deficits in prepulse inhibition of the auditory startle reflex, a finding in human patients with schizophrenia. These studies support the view that PLA2 activity may not only play a crucial role in neurodegeneration, but depending on the isoform, could also be essential in prevention of neuropsychiatric diseases. These findings could open new doors for understanding and treatment of neurodegenerative and neuropsychiatric diseases.
Keywords: Cytosolic phospholipase A2, calcium-independent phospholipase A2, plasmalogen-selective phospholipase A2, secretory phospholipase A2, arachidonic acid, docosahexaenoic acid, reactive oxygen species, oxidative stress, inflammation, excitotoxicity, mitochondna schizophrenia
Current Medicinal Chemistry
Title: Involvement of Cytosolic Phospholipase A2, Calcium Independent Phospholipase A2 and Plasmalogen Selective Phospholipase A2 in Neurodegenerative and Neuropsychiatric Conditions
Volume: 17 Issue: 25
Author(s): W.-Y. Ong, T. Farooqui and A.A. Farooqui
Affiliation:
Keywords: Cytosolic phospholipase A2, calcium-independent phospholipase A2, plasmalogen-selective phospholipase A2, secretory phospholipase A2, arachidonic acid, docosahexaenoic acid, reactive oxygen species, oxidative stress, inflammation, excitotoxicity, mitochondna schizophrenia
Abstract: Enzymes belonging to the PLA2 superfamily catalyze the hydrolysis of unsaturated fatty acids from the sn-2 position of glycerol moiety of neural membrane phospholipids. The PLA2 superfamily is classified into cytosolic PLA2 (cPLA2), calcium-independent PLA2 (iPLA2), plasmalogen-selective PLA2 (PlsEtn-PLA2) and secretory PLA2 (sPLA2). PLA2 paralogs/splice variants/isozymes are part of a complex signal transduction network that maintains cross-talk among excitatory amino acid and dopamine receptors through the generation of second messengers. Individual paralogs, splice variants and multiple forms of PLA2 may have unique enzymatic properties, tissue and subcellular localizations and roles in various physiological and pathological situations, hence tight regulation of all PLA2 isoforms is essential for normal brain function. Quantitative RT-PCR analyses show significantly higher expression of iPLA2 than cPLA2 in all regions of the rat brain. Upregulation of the cPLA2 family is involved in degradation of neural membrane phospholipids and generation of arachidonic acid-derived lipid metabolites that have been implicated in nociception, neuroinflammation, oxidative stress and neurodegeneration. In contrast, studies using a selective iPLA2 inhibitor, bromoenol lactone, or antisense oligonucleotide indicate that iPLA2 is an important “housekeeping” enzyme under normal conditions, whose activity is required for the prevention of vacuous chewing movements, and deficits in prepulse inhibition of the auditory startle reflex, a finding in human patients with schizophrenia. These studies support the view that PLA2 activity may not only play a crucial role in neurodegeneration, but depending on the isoform, could also be essential in prevention of neuropsychiatric diseases. These findings could open new doors for understanding and treatment of neurodegenerative and neuropsychiatric diseases.
Export Options
About this article
Cite this article as:
Ong W.-Y., Farooqui T. and Farooqui A.A., Involvement of Cytosolic Phospholipase A2, Calcium Independent Phospholipase A2 and Plasmalogen Selective Phospholipase A2 in Neurodegenerative and Neuropsychiatric Conditions, Current Medicinal Chemistry 2010; 17 (25) . https://dx.doi.org/10.2174/092986710791859289
DOI https://dx.doi.org/10.2174/092986710791859289 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacological Tools to Activate Microglia and their Possible use to Study Neural Network Patho-physiology
Current Neuropharmacology Conservation of Hydrophobicity within Viral Envelope Glycoproteins Reveals a Putative Hepatitis C Virus Fusion Peptide
Protein & Peptide Letters Mutations of mtDNA in some Vascular and Metabolic Diseases
Current Pharmaceutical Design Old Strategies and New Perspectives in Modulating the Endocannabinoid System
Current Bioactive Compounds The Stroke-Induced Blood-Brain Barrier Disruption: Current Progress of Inspection Technique, Mechanism, and Therapeutic Target
Current Neuropharmacology Entry Inhibitors Directed Towards Glycoprotein gp120: An Overview on a Promising Target for HIV-1 Therapy
Current Medicinal Chemistry Lumiflavin Enhances the Effects of Ionising Radiation on Ovarian Cancer Stem-Like Cells by Inhibiting Autophagy
Anti-Cancer Agents in Medicinal Chemistry Ullrich Congenital Dystrophy and Bethlem Myopathy: Current Knowledge on the Clinical Spectrum, Pathogenesis, and Future Therapeutic Avenues of Collagen VI Related Muscular Dystrophies
Current Pediatric Reviews Non-Nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors: Past, Present, and Future Perspectives
Current Pharmaceutical Design Unique Insights into the Actions of CNS Agents: Lessons from Studies of Chlorpyrifos and Other Common Pesticides
Central Nervous System Agents in Medicinal Chemistry Disulfiram's Anticancer Activity: Evidence and Mechanisms
Anti-Cancer Agents in Medicinal Chemistry Vascular and Cardiac Oxidative Stress and Inflammation as Targets for Cardioprotection
Current Pharmaceutical Design Vitiligo: Pathogenetic Hypotheses and Targets for Current Therapies
Current Drug Metabolism Hereditary Haemorrhagic Teleangiectasia: Diagnostic Imaging of Visceral Involvement
Current Pharmaceutical Design Current Status of the Non-nucleoside Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Type 1
Current Topics in Medicinal Chemistry Therapeutic Potential of Targeting the Endocannabinoids: Implications for the Treatment of Obesity, Metabolic Syndrome, Drug Abuse and Smoking Cessation
Current Medicinal Chemistry CB1 Cannabinoid Receptors and their Associated Proteins
Current Medicinal Chemistry From Physiome to Pathome: A Systems Biology Model of Major Depressive Disorder and the Psycho-Immune-Neuroendocrine Network
Current Psychiatry Reviews Current and Emerging Therapies in Neuroendocrine Tumors: Impact of Genetic Targets on Clinical Outcomes
Clinical Cancer Drugs Dendritic Cell Immunotherapy for Acute Inflammatory Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry